The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Lilly; MSD; Roche; Takeda
Combi-TED: A multicenter, phase II, open-label, randomized trial evaluating efficacy of OSE2021 plus docetaxel or OSE2021 plus nivolumab as second-line therapy in metastatic NSCLC progressing after first-line chemo-immunotherapy.
 
Federico Cappuzzo
Honoraria - AstraZeneca/MedImmune; Lilly; MSD Oncology; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Lilly; MSD Oncology; pfizer; Roche/Genentech; Takeda
Travel, Accommodations, Expenses - OSE Immunotherapeutics
 
Giulia Pasello
No Relationships to Disclose
 
Angelo Delmonte
Consulting or Advisory Role - Novartis; Takeda
Speakers' Bureau - Bristol-Myers Squibb
 
Lorenza Landi
Honoraria - AstraZeneca; Bayer; BRISTOL MYERS SQUIBB; Lilly; Merck; Pfizer; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol Myers Squibb; Lilly; Merck; Pfizer; Roche; Takeda
 
Beatrice Benetti
No Relationships to Disclose
 
Giulio Metro
No Relationships to Disclose
 
Mario Rosario D'Andrea
No Relationships to Disclose
 
Stefania Gori
No Relationships to Disclose
 
Gloria Borra
No Relationships to Disclose
 
Francesca Mazzoni
No Relationships to Disclose
 
Claudio Verusio
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Sandoz
 
Maria Pagano
No Relationships to Disclose
 
Diana Giannarelli
No Relationships to Disclose
 
Andrea Vincent Bonetti
No Relationships to Disclose
 
Michele Maio
Stock and Other Ownership Interests - Epigen Therapeutics; Theravance
Honoraria - Alfasigma; Amgen; AstraZeneca; Bristol-Myers Squibb; Lilly; Merck; MSD; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Alfasigma; AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Pierre Fabre; Roche
Patents, Royalties, Other Intellectual Property - DNA Hypomethylating agents for cancer therapy
Travel, Accommodations, Expenses - Alfasigma; Amgen; AstraZeneca; Bristol-Myers Squibb; Merck; MSD; Pierre Fabre; Roche
 
Antonino Scimone
No Relationships to Disclose
 
Vincenzo Adamo
No Relationships to Disclose